China Ready For More Medtech Market Access Simplifications
Executive Summary
Following the recent news of local trial exemptions for almost 160 types of medical devices and IVDs in China, the China Food and Drug Administration is preparing to introduce more market access regulatory simplifications for medtech companies entering the Chinese market.